ECR 2020 Postponed Amid COVID-19 Epidemic
Conference re-scheduled for July 2020.
The European Society of Radiology (ESR) announced today it will postpone its ECR 2020 conference, scheduled for March 11-15, 2020, due to concerns over the expanding global spread of COVID-19.
The annual meeting is now planned for July 15-19, 2020, in Vienna. According to an ESR statement, registration fees and online services will remain in place for the new date, and registration for the event is still open.
In noting the “safety, health, and well-being” of conference attendees is its highest priority, the ESR reached the decision to cancel after assessing statements from the World Health Organization and the European Center for Disease Control and Prevention about world-wide restrictions and crisis. The organization acknowledged it could not, at this time, fulfill the requirements set forth by the Austrian health authorities to guarantee the health safety of meeting participants and industry partners.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
